Neutrophil granulocytes in ovarian cancer - induction of epithelial-to-mesenchymal-transition and tumor cell migration

Journal of Cancer

Volumn 7, Issue 5, 2016, Pages 546-554

  Mayer, Christine ^a   Darb Esfahani, Silvia ^b,c   Meyer, Anne Sophie ^a   Hübner, Katrin ^d   Rom, Joachim ^a   Sohn, Christof ^a   Braicu, Ioana ^b,c   Sehouli, Jalid ^b,c   Hänsch, G Maria ^a   Gaida, Matthias M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Tumor Bank Ovarian Cancer Network (TOC)   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Epithelial to mesenchymal transition; Migration; Neutrophil elastase; Neutrophils; Ovarian cancer; Tumor microenvironment

Indexed keywords

BETA CATENIN; CD15 ANTIGEN; CYTOKERATIN; LEUKOCYTE ELASTASE; UVOMORULIN;

ADULT; ARTICLE; CANCER CELL; CELL GROWTH; CELL LYSATE; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; OVARIAN CANCER CELL LINE; OVARY CANCER; PHENOTYPE; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; WOUND HEALING;

EID: 84971553932     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.14169     Document Type: Article

References (35)

1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2015. CA Cancer J Clin 2015, 65:5-29.
2. McGuire WP, Brady MF, Ozols RF: The Gynecologic Oncology Group experience in ovarian cancer. Ann Oncol 1999, 10 Suppl 1:29-34.
3. Parmar MKB, Ledermann JA, Colombo N, du Bois A, Delaloye J-F, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Tropé C: Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet (London, England) 2003, 361:2099-106.
4. Balkwill FR, Capasso M, Hagemann T: The tumor microenvironment at a glance. J Cell Sci 2012, 125(Pt 23):5591-6.
5. Musrap N, Diamandis EP: Revisiting the complexity of the ovarian cancer microenvironment-clinical implications for treatment strategies. Mol Cancer Res 2012, 10:1254-64.
6. Lichtenstein A, Seelig M, Berek J, Zighelboim J: Human neutrophil-mediated lysis of ovarian cancer cells. Blood 1989, 74:805-9.
7. Williams KA, Labidi-Galy SI, Terry KL, Vitonis AF, Welch WR, Goodman A, Cramer DW: Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecol Oncol 2014, 132:542-50.
8. Cho KR: Ovarian cancer update: lessons from morphology, molecules, and mice. Arch Pathol Lab Med 2009, 133:1775-81.
9. Klink M, Jastrzembska K, Nowak M, Bednarska K, Szpakowski M, Szyllo K, Sulowska Z: Ovarian cancer cells modulate human blood neutrophils response to activation in vitro. Scand J Immunol 2008, 68:328-36.
10. Aeed PA, Nakajima M, Welch DR: The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. Int J Cancer 1988, 42:748-59.
11. Welch DR, Schissel DJ, Howrey RP, Aeed PA: Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci U S A 1989, 86:5859-63.
12. Marzano A V, Cugno M, Trevisan V, Lazzari R, Fanoni D, Berti E, Crosti C: Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses. Int J Immunopathol Pharmacol, 2011;24:451-60.
13. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-42.
14. Jeanes A, Gottardi CJ, Yap AS: Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 2008, 27:6920-9.
15. Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO: E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 2005, 46:685-93.
16. Baranwal S, Alahari SK: Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 2009, 384:6-11.
17. Stockmeyer B, Beyer T, Neuhuber W, Repp R, Kalden JR, Valerius T, Herrmann M: Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells. J Immunol 2003, 171:5124-9.
18. Otten MA, Rudolph E, Dechant M, Tuk CW, Reijmers RM, Beelen RHJ, van de Winkel JGJ, van Egmond M: Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J Immunol 2005, 174:5472-80.
19. Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AAR, Wauters E, Walmsley S, Prenen H, Granot Z, Casazza A, Mazzone M: MET is required for the recruitment of anti-tumoural neutrophils. Nature 2015, 522:349-53.
20. Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau C-S, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, de Visser KE: IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015, 522:345-8.
21. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM: Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-94.
22. Houghton AM, Rzymkiewicz DM, Ji H, Gregory AD, Egea EE, Metz HE, Stolz DB, Land SR, Marconcini LA, Kliment CR, Jenkins KM, Beaulieu KA, Mouded M, Frank SJ, Wong KK, Shapiro SD: Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 2010, 16:219-23.
23. Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Lopes CS: Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas. Ann Oncol 2004, 15:1535-42.
24. Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Ferreira VM, Lopes CS: Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Hum Pathol 2004, 35:663-9.
25. Qiu X, Cheng J-C, Klausen C, Fan Q, Chang H-M, So W-K, Leung PCK: Transforming growth factor-a induces human ovarian cancer cell invasion by down-regulating E-cadherin in a Snail-independent manner. Biochem Biophys Res Commun 2015, 461:128-35.
26. So W-K, Fan Q, Lau M-T, Qiu X, Cheng J-C, Leung PCK: Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression. FEBS Lett 2014, 588:3998-4007.
27. Cheng J-C, Klausen C, Leung PCK: Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. Cancer Lett 2013, 329:197-206.
28. Lau M-T, So W-K, Leung PCK: Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells. PLoS One 2013, 8:e59083.
29. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-8.
30. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD: Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998, 4:615-8.
31. Gaida MM, Steffen TG, Günther F, Tschaharganeh DF, Felix K, Bergmann F, Schirmacher P, Hänsch GM: Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors. Eur J Immunol 2012, 42:3369-80.
32. Cui T, Srivastava AK, Han C, Yang L, Zhao R, Zou N, Qu M, Duan W, Zhang X, Wang Q-E: XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression. Oncotarget 2015, 6:10060-72.
33. Bi X, Pohl NM, Qian Z, Yang GR, Gou Y, Guzman G, Kajdacsy-Balla A, Iozzo R V, Yang W: Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 2012, 33:326-30.
34. Grosse-Steffen T, Giese T, Giese N, Longerich T, Schirmacher P, Hänsch GM, Gaida MM: Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. Clin Dev Immunol 2012, 2012:720768.
35. Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S: EMT and tumor metastasis. Clin Transl Med 2015, 4:6.